Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,012 stories, page 695 of 767

Advanced search

🇺🇸Mar 3Devicespathai.comTier 1 · Company source

PathAI Receives U.S. FDA Breakthrough Device Designation for PathAssist Derm, an AI-Powered Pathology Solution to Transform Dermatopathology Workflow

PathAIOriginal source

🌍Mar 3Industrysubtlemedical.comTier 1 · Company source

Subtle Medical Advances the Future of AI-Powered Imaging at ECR 2026

Subtle MedicalOriginal source

🌍Mar 3Mediaoxipit.aiTier 2 · Direct publisher

German Medical Institute selects Oxipit AI following independent 700 case clinical evaluation

Oxipit (ChestLink for Thoracic X-ray/CT)Original source

🇯🇵Mar 3Devicessysmex.co.jpTier 1 · Company source

Shiga University of Medical Science and Sysmex Identify Factors Associated with Blood-Based Biomarkers Related to Alzheimer's Disease in General Japanese Men

Sysmex (Global)Original source

🌍Mar 3Industryalloytx.comTier 1 · Company source

Rethinking Antisense Architecture with Transient Cyclic Oligonucleotides for Next-Generation RNA Therapeutics

Alloy TherapeuticsOriginal source

🇮🇹Mar 2Mediamg2.itTier 2 · Direct publisher

MG2 celebra 60 anni di innovazione nelle macchine automatiche per la farmaceutica e nutraceutica

MG2 s.r.l.Original source

🇮🇹Mar 2Mediamg2.itTier 2 · Direct publisher

MG2 celebrates 60 years of innovation in automatic machines for the pharmaceutical and nutraceutical industries

MG2 s.r.l.Original source

🌍Mar 2Industryir.talphera.comTier 1 · Company source

Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial

TalpheraOriginal source

🇸🇪Mar 2CDMOrecipharm.comTier 2 · Direct publisher

Recipharm Advanced Bio to deliver series of seminar to U.S. FDA showcasing novel PAT and digital infrastructure to enable real-time testing and continuous biomanufacturing

Recipharm PressOriginal source

🇺🇰Mar 2Researchuclh.nhs.ukTier 2 · Direct publisher

Urgent call to improve survival for bile duct cancer patients

University College London Hospitals (UCLH)Original source

🇯🇵Mar 2Devicesolympus-global.comTier 1 · Company source

Sharing the Importance of Screening Through the Experience of a Colorectal Cancer Survivor — A “True to Life” Story

Olympus MedicalOriginal source

🌍Mar 2Industryintercure.coTier 1 · Company source

6-K (Current report)

InterCureOriginal source

🇺🇸Feb 27Industryclinicalink.comTier 1 · Company source

Clinical ink Appoints Dr. Christian Born Djurhuus, MD, PhD as Chief Science Officer

Clinical InkOriginal source

🇸🇬Feb 27Researchscri.edu.sgTier 2 · Direct publisher

Clinical Research Coordinator Level 2 Programme

Singapore Clinical Research InstituteOriginal source

🇸🇬Feb 27Researchscri.edu.sgTier 2 · Direct publisher

Clinical Research Coordinator Level 1 Programme

Singapore Clinical Research InstituteOriginal source

🇺🇸Feb 27CROcelerion.comTier 2 · Direct publisher

The Resurgence of Antibody Drug Conjugates: How ADCs are taking over oncology (again) and what we’ve learned about creating bioanalytical methods to support preclinical and clinical success.

CelerionOriginal source

🇯🇵Feb 27CROen.cmicgroup.comTier 2 · Direct publisher

Lunch & Learn – Powering Global Drug Development: Unlocking Japan & APAC’s Competitive Edge

CMIC Group JapanOriginal source

🌍Feb 26Mediainsitro.comTier 2 · Direct publisher

insitro Appoints Joe Hand as Chief People Officer to Advance Talent Strategy for Next Stage of Development

InsitroOriginal source

🇫🇷Feb 26Industrypierre-fabre.comTier 1 · Company source

MARS BLEU - Mois de sensibilisation à la prévention du cancer colorectal

Pierre FabreOriginal source

🌍Feb 26Industrypsomagen.comTier 1 · Company source

Psomagen and OmicInsight Partner for Advanced Subcellular Imaging and Data Analysis

PsomagenOriginal source

🇺🇸Feb 26Industryvikingtherapeutics.comTier 1 · Company source

Brandon D. Porter, Esq., M.B.A - Viking Therapeutics

Viking Therapeutics (IR)Original source

🇺🇸Feb 26Industryvikingtherapeutics.comTier 1 · Company source

Kenneth J. Herman - Viking Therapeutics

Viking Therapeutics (IR)Original source

🇫🇷Feb 26Researchpresse.inserm.frTier 2 · Direct publisher

When sleep apnea causes metabolic jet lag

INSERMOriginal source

🇮🇹Feb 25Mediamg2.itTier 2 · Direct publisher

Assistenza tecnica e post vendita: un dialogo costante a supporto del cliente

MG2 s.r.l.Original source

🇮🇹Feb 25Mediamg2.itTier 2 · Direct publisher

Technical Assistance and After Sales Support: a continuous dialogue at the customer’s side

MG2 s.r.l.Original source

🇺🇸Feb 25Researchpodcasters.spotify.comTier 3 · Secondary coverage

Trouncing career regret with famed VC Bill Gurley

Lux CapitalOriginal source

🇺🇸Feb 25Researchmdanderson.orgTier 2 · Direct publisher

What is personalized ovarian cancer treatment?

MD Anderson Cancer CenterOriginal source

🇯🇵Feb 25Devicesolympus-global.comTier 1 · Company source

I Feel Like I Got a Second Chance": An Engineer’s Journey with Bronchial Valves — A “True to Life” Story

Olympus MedicalOriginal source

🇮🇱Feb 25Industryir.tevapharm.comTier 1 · Company source

Teva to Present at the Upcoming Investor Conferences in March

Teva Pharmaceuticals RSSOriginal source

🌍Feb 25Medianorstella.comTier 2 · Trade media

Inside the Norstella Panel: The engine behind smarter access decisions

Norstella (Citeline + Evaluate + MMIT AI)Original source

🌍Feb 24Industrycytomx.comTier 1 · Company source

Varsetatug masetecan (CX-2051): Unlocking EpCAM as a Cancer Target via a Masked EPCAM-Directed Topo1 ADC

CytomX TherapeuticsOriginal source

🌍Feb 24Regulatoryinfarma.plTier 1 · Regulatory source

35 000 dodatkowych pacjentów uzyska dostęp do badań klinicznych, jeśli nowe cele UE zostaną osiągnięte

INFARMA PolandOriginal source

🌍Feb 24Industryaptose.comTier 1 · Company source

Aptose Biosciences Announces Amendment to Arrangement Agreement and Details of Postponed Special Meeting of Shareholders

Aptose BiosciencesOriginal source

🇺🇰Feb 24Researchuclh.nhs.ukTier 2 · Direct publisher

Interventions for prostate cancer patients on active surveillance: what our patients should know

University College London Hospitals (UCLH)Original source

🌍Feb 24Industrymeridianbioscience.comTier 1 · Company source

What Would It Take to Bring NGS to the Point of Need

Meridian BioscienceOriginal source

🌍Feb 24Mediaechonous.comTier 2 · Direct publisher

What Is the “Best” Point-of-Care Ultrasound? A Clinician-Centered Framework

EchoNousOriginal source

🇺🇰Feb 23Researchphar.cam.ac.ukTier 2 · Direct publisher

MAST Platform secures additional £1.2 million award

Cambridge Pharma ResearchOriginal source

🇺🇸Feb 23Devicespathai.comTier 1 · Company source

Labcorp Expands Collaboration with PathAI to Deploy FDA-Cleared Digital Pathology Platform Nationwide

PathAIOriginal source

🌍Feb 23Industrybenitec.comTier 1 · Company source

Benitec Biopharma Announces Acceptance of Late- Breaking Abstract for the BB-301 Phase 1b/2a Clinical Treatment Study at the Muscular Dystrophy Association Clinical & Scientific Conference

Benitec BiopharmaOriginal source

🇮🇹Feb 23CDMOflammagroup.comTier 2 · Direct publisher

Flamma USA Successfully Passes FDA Inspection

Flamma GroupOriginal source

🌍Feb 23Industrymeridianbioscience.comTier 1 · Company source

Meridian Bioscience Achieves IVDR Certification for Alethia® Molecular Assay Portfolio

Meridian BioscienceOriginal source

🇮🇱Feb 21Industryir.tevapharm.comTier 1 · Company source

U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults

Teva Pharmaceuticals RSSOriginal source

🇨🇭Feb 20CDMOsiegfried.chTier 2 · Direct publisher

Siegfried delivers strong profitability and continued growth

SiegfriedOriginal source

🇯🇵Feb 20Devicessysmex.co.jpTier 1 · Company source

Sysmex Ranked in the Top 1% in the Sustainability Yearbook 2026 by S&P Global

Sysmex (Global)Original source

🌍Feb 20Industrybicara.comTier 1 · Company source

MHNCS 2026 Oral Presentation: Ficerafusp alfa (2000mg Q2W) and pembrolizumab in HPV-negative first-line recurrent/metastatic head and neck squamous cell carcinoma

Bicara TherapeuticsOriginal source

🇺🇸Feb 20Industryelementbiosciences.comTier 1 · Company source

Element Biosciences Introduces VITARI™, Redefining What High-Throughput Sequencing Makes Possible

Element BiosciencesOriginal source

🇺🇸Feb 20Researcharchventure.comTier 2 · Direct publisher

ARCH’s Carol Suh named to National Venture Capital Association’s 2026 List of Rising Stars

ARCH Venture PartnersOriginal source

🇫🇷Feb 19Industrypierre-fabre.comTier 1 · Company source

Les Laboratoires Pierre Fabre explorent le potentiel de l’Intelligence Artificielle pour lancer une nouvelle génération d’études cliniques en dermo-cosmétique

Pierre FabreOriginal source

🌍Feb 19Industryuk-cpi.comTier 1 · Company source

CPI leads UK biomanufacturing and pharma SME delegation on strategic visit to India

CPI (Healthcare Innovation)Original source

🇸🇪Feb 19CDMOrecipharm.comTier 2 · Direct publisher

Recipharm strengthens high potency capabilities with new pilot and development investment

Recipharm PressOriginal source

🌍Feb 18Industrymeridianbioscience.comTier 1 · Company source

Meridian Life Science Expands Ambient-Stable NGS Portfolio with the Launch of a Lyophilized Enzymatic DNA Fragmentation Kit.

Meridian BioscienceOriginal source

🇫🇷Feb 18CDMOaxplora.comTier 3 · Secondary coverage

Axplora announces multi-million-euro investment to expand lyophilization at Le Mans and appoints François Houbart as Head of Site

NovasepOriginal source

🌍Feb 18Industryintercure.coTier 1 · Company source

6-K (Current report)

InterCureOriginal source

🇺🇸Feb 18Devicesparagon28.comTier 1 · Company source

Zimmer Biomet Launches Advancement for Hindfoot Fusion

Paragon 28Original source

🇺🇸Feb 18Industryneogenomics.comTier 1 · Company source

test search

NeoGenomicsOriginal source

🌍Feb 18Regulatoryinfarma.plTier 1 · Regulatory source

Aleksander Kwieciński został wybrany na stanowisko Przewodniczącego Rady Nadzorczej INFARMY.

INFARMA PolandOriginal source

🌍Feb 17Regulatoryravimiamet.eeTier 1 · Regulatory source

The Estonian Medicinal Products Market in the Fourth Quarter 2025

SAM EstoniaOriginal source

🌍Feb 17Industrynimbustx.comTier 1 · Company source

Nimbus Therapeutics to Present Preclinical and Translational Data on Novel SIK2 Inhibitors at 21st Congress of European Crohn’s and Colitis Organisation (ECCO)

Nimbus TherapeuticsOriginal source

🇮🇱Feb 17Industryir.tevapharm.comTier 1 · Company source

Teva and Sanofi’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn’s disease

Teva Pharmaceuticals RSSOriginal source

🇧🇪Feb 17Regulatoryfamhp.beTier 1 · Regulatory source

"Paracetamol challenge" : a reminder of the risks associated with overdosing and rules for proper use

FAMHP (Belgium)Original source